The AONYS® platform is able to formulate water soluble active ingredients of various sizes such as metal ions, chelating molecules, peptides and oligonucleotides. In addition, stable ultra-small nanoparticles may be manufactured in situ, opening up new opportunities in the field of nano-medicine.

Therapeutic areas under development:

  • Neurodegenerative diseases with lithium ion
    • Alzheimer’s disease
  • Huntington’s disease with siRNAs targeting the mutant Huntingtin
  • Acute Respiratory Distress Syndrome / COVID-19 with Manganese ion
  • COVID-19 with an siRNA targeting the virus genome
  • Decorporation of cesium with chelating molecules
  • Radioprotection and radiomitigation after nuclear irradiation

Research therapeutic areas:

  • Customized treatment of resistant cancers with siRNAs and peptides
  • Oncology collaboration with the company Transgene
Share:Share on Facebook
Facebook